Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Newly diagnosed multiple sclerosis in state of Qatar.
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
Pages
« first
‹ previous
…
174
175
176
177
178
179
180
181
182
…
next ›
last »